Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Immunoglobulin Heavy Chains | 3 | 2021 | 646 | 1.090 |
Why?
|
| Antibody Affinity | 2 | 2021 | 249 | 0.850 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 2 | 2021 | 103 | 0.730 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2020 | 375 | 0.690 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2021 | 288 | 0.680 |
Why?
|
| HIV Antibodies | 4 | 2022 | 1335 | 0.640 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2022 | 545 | 0.630 |
Why?
|
| AIDS Vaccines | 2 | 2020 | 896 | 0.550 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2016 | 99 | 0.520 |
Why?
|
| Immunoglobulin Switch Region | 5 | 2006 | 44 | 0.480 |
Why?
|
| Immunoglobulin Class Switching | 6 | 2006 | 289 | 0.430 |
Why?
|
| Antibodies, Neutralizing | 5 | 2022 | 2005 | 0.420 |
Why?
|
| Mammals | 1 | 2018 | 1136 | 0.420 |
Why?
|
| Immunization | 1 | 2016 | 1220 | 0.400 |
Why?
|
| Antibodies | 1 | 2018 | 2426 | 0.350 |
Why?
|
| HIV-1 | 4 | 2022 | 6909 | 0.320 |
Why?
|
| HIV Seropositivity | 2 | 2022 | 963 | 0.260 |
Why?
|
| B-Lymphocytes | 6 | 2020 | 4779 | 0.240 |
Why?
|
| Recombination, Genetic | 4 | 2006 | 1524 | 0.230 |
Why?
|
| Xeroderma Pigmentosum | 1 | 2004 | 31 | 0.230 |
Why?
|
| Genes, Lethal | 1 | 2004 | 223 | 0.220 |
Why?
|
| Isoflurane | 3 | 2011 | 384 | 0.200 |
Why?
|
| Cytidine Deaminase | 4 | 2006 | 243 | 0.200 |
Why?
|
| Ultraviolet Rays | 2 | 2004 | 1100 | 0.200 |
Why?
|
| Conserved Sequence | 1 | 2004 | 1163 | 0.190 |
Why?
|
| Endonucleases | 1 | 2004 | 371 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 3 | 2011 | 575 | 0.180 |
Why?
|
| Epitopes | 3 | 2022 | 2523 | 0.170 |
Why?
|
| Mice | 16 | 2022 | 82051 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9261 | 0.160 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2020 | 161 | 0.160 |
Why?
|
| DNA Repair | 3 | 2006 | 2051 | 0.150 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 9623 | 0.150 |
Why?
|
| HIV Infections | 2 | 2022 | 17492 | 0.140 |
Why?
|
| Sequence Deletion | 2 | 2016 | 1496 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1894 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 467 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2020 | 880 | 0.130 |
Why?
|
| Animals | 18 | 2022 | 169424 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2019 | 874 | 0.120 |
Why?
|
| Antigen Presentation | 1 | 2020 | 1247 | 0.120 |
Why?
|
| Vaccines | 1 | 2022 | 845 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2020 | 781 | 0.100 |
Why?
|
| Hybridomas | 4 | 2006 | 444 | 0.100 |
Why?
|
| Lymphocyte Activation | 3 | 2020 | 5490 | 0.090 |
Why?
|
| Mice, Mutant Strains | 3 | 2019 | 1755 | 0.090 |
Why?
|
| Software | 1 | 2024 | 4465 | 0.080 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 1885 | 0.080 |
Why?
|
| Caspase 3 | 2 | 2009 | 732 | 0.080 |
Why?
|
| Base Sequence | 6 | 2006 | 12426 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2238 | 0.080 |
Why?
|
| Nitrous Oxide | 1 | 2009 | 166 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 18390 | 0.080 |
Why?
|
| Point Mutation | 2 | 2004 | 1596 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2006 | 166 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2009 | 3892 | 0.060 |
Why?
|
| Deamination | 1 | 2004 | 25 | 0.060 |
Why?
|
| Replication Protein A | 1 | 2004 | 54 | 0.060 |
Why?
|
| Cell Line | 2 | 2016 | 15610 | 0.060 |
Why?
|
| Algorithms | 1 | 2024 | 14157 | 0.050 |
Why?
|
| Cytidine | 1 | 2003 | 60 | 0.050 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 2022 | 64 | 0.050 |
Why?
|
| Mitomycin | 1 | 2004 | 264 | 0.050 |
Why?
|
| Complementarity Determining Regions | 1 | 2022 | 150 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2006 | 614 | 0.050 |
Why?
|
| Genes, Immunoglobulin | 1 | 2002 | 286 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 1688 | 0.050 |
Why?
|
| Gene Library | 1 | 2024 | 1064 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2022 | 265 | 0.050 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 692 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1992 | 0.040 |
Why?
|
| Xenopus laevis | 1 | 2004 | 966 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2004 | 2184 | 0.040 |
Why?
|
| DNA | 2 | 2004 | 7213 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3210 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11928 | 0.040 |
Why?
|
| Mutation | 4 | 2019 | 30235 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2016 | 10269 | 0.040 |
Why?
|
| Spleen | 1 | 2004 | 2298 | 0.040 |
Why?
|
| Macaca | 1 | 2019 | 417 | 0.040 |
Why?
|
| Gene Knock-In Techniques | 1 | 2019 | 423 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2006 | 17637 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2011 | 3984 | 0.040 |
Why?
|
| Carbamates | 2 | 2009 | 192 | 0.040 |
Why?
|
| Dipeptides | 2 | 2009 | 386 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2006 | 4570 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2003 | 7602 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2009 | 619 | 0.030 |
Why?
|
| Cognition | 1 | 2011 | 7062 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9526 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2004 | 4180 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 4774 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 3594 | 0.030 |
Why?
|
| Humans | 12 | 2022 | 768369 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 3669 | 0.020 |
Why?
|
| DNA, Single-Stranded | 2 | 2003 | 354 | 0.020 |
Why?
|
| Skin | 1 | 2004 | 4520 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5808 | 0.020 |
Why?
|
| Anesthesia, Spinal | 1 | 2011 | 282 | 0.020 |
Why?
|
| Clioquinol | 1 | 2008 | 23 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2009 | 616 | 0.020 |
Why?
|
| Genomics | 1 | 2024 | 5912 | 0.020 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2006 | 57 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 428 | 0.020 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2008 | 309 | 0.020 |
Why?
|
| Phenotype | 1 | 2004 | 16712 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 661 | 0.020 |
Why?
|
| China | 1 | 2011 | 2397 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 2005 | 455 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2004 | 12176 | 0.010 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 1115 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Amination | 1 | 2003 | 18 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2006 | 842 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 2003 | 189 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6242 | 0.010 |
Why?
|
| Base Composition | 1 | 2003 | 291 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2008 | 1193 | 0.010 |
Why?
|
| Models, Genetic | 2 | 2003 | 3442 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 816 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3813 | 0.010 |
Why?
|
| Genes, Switch | 1 | 2002 | 48 | 0.010 |
Why?
|
| Actins | 1 | 2009 | 2064 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 17149 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2009 | 5042 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 454 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2002 | 851 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2006 | 1528 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2002 | 111 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2003 | 516 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1969 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 1249 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2003 | 1775 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3734 | 0.010 |
Why?
|
| Boston | 1 | 2011 | 9359 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 7133 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2011 | 8730 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2825 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2006 | 1841 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2002 | 1139 | 0.010 |
Why?
|
| Cells, Cultured | 2 | 2003 | 19035 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 4174 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2006 | 2680 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2002 | 1781 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 6527 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 9505 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 6880 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 9504 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 40271 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 22365 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2011 | 54913 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2011 | 65408 | 0.000 |
Why?
|
| Aged | 1 | 2011 | 171514 | 0.000 |
Why?
|
| Middle Aged | 1 | 2011 | 223406 | 0.000 |
Why?
|
| Male | 1 | 2011 | 364761 | 0.000 |
Why?
|
| Neoplasms | 1 | 2002 | 22389 | 0.000 |
Why?
|
| Female | 1 | 2011 | 396926 | 0.000 |
Why?
|
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(21)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_